Ignite Creation Date:
2025-12-24 @ 2:50 PM
Ignite Modification Date:
2025-12-27 @ 8:11 AM
Study NCT ID:
NCT04624659
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-02
First Post:
2020-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)
Sponsor:
Forma Therapeutics, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sickle Cell Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Sickle Cell Disease | View |
| None | Sickle Cell | View |
| None | Anemia | View |
| None | Sickle Cell Anemia | View |
| None | Hemolytic | View |
| None | Hemoglobin | View |
| None | Vaso-occlusive Crisis | View |
| None | Sickle Cell Crisis | View |
| None | Congenital Anemia | View |
| None | Hemolytic Anemia | View |
| None | Hematologic Disease | View |
| None | Hemoglobinopathies | View |
| None | Genetic Disease | View |
| None | Inborn Disease | View |
| None | Sickle Cell Trait | View |
| None | Pyruvate Kinase | View |